Autoantigens and microbial pathogens activate BCR signaling and promote tolerogenic mechanisms such as receptor editing/revision, anergy, CD5+ expression, and somatic hypermutation in CLL B cells. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.